Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 47
Filtrar
1.
Toxins (Basel) ; 13(9)2021 09 15.
Artigo em Inglês | MEDLINE | ID: mdl-34564658

RESUMO

The global exploration of snakebites requires the use of quantitative omics approaches to characterize snake venom as it enters into the systemic circulation. These omics approaches give insights into the venom proteome, but a further exploration is warranted to analyze the venom-reactome for the identification of snake venom biomarkers. The recent discovery of extracellular vesicles (EVs), and their critical cellular functions, has presented them as intriguing sources for biomarker discovery and disease diagnosis. Herein, we purified EV's from the snake venom (svEVs) of Crotalus atrox and C. oreganus helleri, and from plasma of BALB/c mice injected with venom from each snake using EVtrap in conjunction with quantitative mass spectrometry for the proteomic identification and quantification of svEVs and plasma biomarkers. Snake venom EVs from C. atrox and C. o. helleri were highly enriched in 5' nucleosidase, L-amino acid oxidase, and metalloproteinases. In mouse plasma EVs, a bioinformatic analysis for revealed upregulated responses involved with cytochrome P450, lipid metabolism, acute phase inflammation immune, and heat shock responses, while downregulated proteins were associated with mitochondrial electron transport, NADH, TCA, cortical cytoskeleton, reticulum stress, and oxidative reduction. Altogether, this analysis will provide direct evidence for svEVs composition and observation of the physiological changes of an envenomated organism.


Assuntos
Biomarcadores/metabolismo , Venenos de Crotalídeos/sangue , Venenos de Crotalídeos/química , Venenos de Crotalídeos/metabolismo , Venenos de Crotalídeos/toxicidade , Crotalus , Vesículas Extracelulares/metabolismo , Camundongos Endogâmicos BALB C/sangue , Animais , Biomarcadores/sangue , Camundongos , Camundongos Endogâmicos BALB C/metabolismo , Modelos Animais , Proteômica/métodos
2.
Toxins (Basel) ; 12(7)2020 07 17.
Artigo em Inglês | MEDLINE | ID: mdl-32708875

RESUMO

The most abundant protein families in viper venoms are Snake Venom Metalloproteases (SVMPs), Snake Venom Serine Proteases (SVSPs) and Phospholipases (PLA2s). These are primarily responsible for the pathophysiology caused by the bite of pit-vipers; however, there are few studies that analyze the pharmacokinetics (PK) of whole venom (WV) and its protein families. We studied the pathophysiology, PK profile and differential absorption of representative toxins from venom of Neotropical Rattlesnake (Crotalus simus) in a large animal model (ovine). Toxins studied included crotoxin (the main lethal component), which causes moderate to severe neurotoxicity; SVSPs, which deplete fibrinogen; and SVMPs, which cause local tissue damage and local and systemic hemorrhage. We found that Whole Venom (WV) was highly bioavailable (86%) 60 h following intramuscular (IM) injection, and extrapolation suggests that bioavailability may be as high as 92%. PK profiles of individual toxins were consistent with their physicochemical properties and expected clinical effects. Lymph cannulated animals absorbed 1.9% of WV through lymph during the first 12 h. Crotoxin was minimally detectable in serum after intravenous (IV) injection; however, following IM injection it was detected in lymph but not in blood. This suggests that crotoxin is quickly released from the blood toward its tissue targets.


Assuntos
Venenos de Crotalídeos/farmacocinética , Crotalus , Linfa/metabolismo , Animais , Disponibilidade Biológica , Coagulação Sanguínea/efeitos dos fármacos , Venenos de Crotalídeos/administração & dosagem , Venenos de Crotalídeos/sangue , Venenos de Crotalídeos/toxicidade , Crotoxina/sangue , Crotoxina/farmacocinética , Fibrinogênio/metabolismo , Hemorragia/induzido quimicamente , Injeções Intramusculares , Injeções Intravenosas , Masculino , Metaloproteases/sangue , Metaloproteases/farmacocinética , Serina Proteases/sangue , Serina Proteases/farmacocinética , Carneiro Doméstico
3.
Clin Toxicol (Phila) ; 54(3): 271-6, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26795406

RESUMO

CONTEXT: In light of the existing controversy regarding antivenin treatment for copperhead envenomation, a more detailed analysis of the disability from this species is needed. OBJECTIVE: Our objective was to prospectively determine the duration of pain, swelling, and functional disability, i.e., residual venom effects, in patients with copperhead envenomation. METHODS: Patients with venomous snakebite reported to the North Texas Poison Center between April 2009 and November 2011 were assessed. Patients with confirmed envenomations were contacted by a specialist in poison information. Day zero was the day of the bite and verbal phone consent for study enrollment was obtained at that time. The patient (or their guardian) was contacted by phone daily thereafter, and asked to rate their pain, edema/swelling, and disability using the modified DASH and LEFS scales. Patients were followed to resolution of all symptoms or return to baseline. RESULTS: About 104 cases of venomous snakebite were followed; of which 17 were excluded due to being a dry bites (5) or for having insufficient data during follow-up (11) or due to coagulopathy (1). Overall, residual venom effects from copperhead bites for most patients last between 7 and 13 days. Median time to complete pain resolution was 7 days (mean = 10.7 days). Median length of time to resolution of swelling was 10 days (mean = 13 days) and median length of time to resolution of functional disability was 9 days (mean = 12.2 days). DISCUSSION: Residual venom effects from copperhead envenomation in this study had a slightly shorter duration than some other studies. Data are skewed due to outliers where residual venom effects lasted for up to 89 days. Initial reoccurrence of some symptoms may be seen. Antivenom (AV) is currently being used for a large percentage of patients with copperhead envenomation. Finally, no differences in duration of venom effects were seen based on age or location of bite. CONCLUSION: Our study suggests that residual venom effects from copperhead species persist for between 10 and 13 days but may persist for months. Future studies are necessary to identify risk factors for severe/prolonged injury and to define the benefit of AV in patients with copperhead envenomation.


Assuntos
Agkistrodon , Avaliação da Deficiência , Edema/induzido quimicamente , Edema/diagnóstico , Dor/induzido quimicamente , Dor/diagnóstico , Mordeduras de Serpentes/patologia , Adolescente , Adulto , Idoso , Animais , Antivenenos/uso terapêutico , Criança , Pré-Escolar , Venenos de Crotalídeos/sangue , Feminino , Seguimentos , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Medição da Dor , Estudos Prospectivos , Mordeduras de Serpentes/tratamento farmacológico , Texas , Resultado do Tratamento , Adulto Jovem
4.
Cytometry B Clin Cytom ; 86(6): 397-409, 2014 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-24677789

RESUMO

BACKGROUND: A clinically relevant bleeding diathesis is a frequent diagnostic challenge, which sometimes remains unexplained despite extensive investigations. The aim of our work was to evaluate the diagnostic utility of functional platelet testing by flow cytometry in this context. METHODS: In case of negative results after standard laboratory workup, flow cytometric analysis (FCA) of platelet function was done. We performed analysis of surface glycoproteins Ibα, IIb, IIIa; P-selectin expression and PAC-1 binding after graded doses of ADP, collagen, and thrombin; content/secretion of dense granules; and ability to generate procoagulant platelets. RESULTS: Of 437 patients investigated with standard tests between January 2007 and December 2011, we identified 67 (15.3%) with high bleeding scores and nondiagnostic standard laboratory workup including platelet aggregation studies. Among these patients, FCA revealed some potentially causative platelet defects: decreased dense granule content/secretion (n = 13); decreased α-granule secretion induced by ADP (n = 10), convulxin (n = 4), or thrombin (n = 3); decreased fibrinogen receptor activation induced by ADP (n = 11), convulxin (n = 11), or thrombin (n = 8); and decreased generation of COAT platelets, that is, highly procoagulant platelets induced by simultaneous activation with collagen and thrombin (n = 16). CONCLUSION: Our work confirms that storage pool defects are frequent in patients with a bleeding diathesis and normal coagulation and platelet aggregations studies. Additionally, FCA is able to identify discrete platelet activation defects. In particular, we show for the first time that a relevant proportion of these patients has an isolated impaired ability to generate COAT platelets--a conceptually new defect in platelet procoagulant activity, which is missed by conventional laboratory workup.


Assuntos
Transtornos Plaquetários/sangue , Plaquetas/patologia , Hemorragia/sangue , Transtornos Hemorrágicos/sangue , Agregação Plaquetária/fisiologia , Adolescente , Adulto , Idoso , Coagulação Sanguínea , Transtornos Plaquetários/patologia , Colágeno/metabolismo , Venenos de Crotalídeos/sangue , Venenos de Crotalídeos/metabolismo , Suscetibilidade a Doenças , Feminino , Citometria de Fluxo/métodos , Hemorragia/patologia , Transtornos Hemorrágicos/patologia , Humanos , Lectinas Tipo C/sangue , Lectinas Tipo C/metabolismo , Masculino , Pessoa de Meia-Idade , Selectina-P/sangue , Ativação Plaquetária/fisiologia , Glicoproteínas da Membrana de Plaquetas/metabolismo , Trombina/metabolismo , Adulto Jovem
5.
Clin Toxicol (Phila) ; 51(7): 527-31, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23879180

RESUMO

CONTEXT: Limited information exists on the coagulopathy caused by hump-nosed pit viper (Hypnale hypnale) envenoming. OBJECTIVES: This study aimed to characterise the coagulopathy in hump-nosed pit viper bites by measuring laboratory clotting times and factor studies. MATERIALS AND METHODS: Cases of hump-nosed pit viper envenoming were included from a prospective cohort study of Sri Lankan snake-bite patients. Patient age, sex, snake identification, time of bite and clinical effects were recorded. Patients did not receive anti-venom because no specific anti-venom to hump-nosed vipers exists. All patients received supportive care and serial 20-min whole blood clotting tests (WBCT20). The prothrombin time (PT), international normalised ratio (INR), activated partial thromboplastin time (aPTT), coagulation factors I, II, V, VII, VIII, IX and X, von Willebrand factor (vWF) antigen and D-Dimer concentrations were measured. The median of highest or lowest test result for each patient was reported with interquartile range (IQR). Results. There were 80 hump-nosed pit viper bites, median age was 37 years (IQR: 26-51 years) and 48 were male. The WBCT20 was positive in one patient. The median highest INR was 1.9 (1.5-2.2; Range: 1.3 to > 12) and median highest aPTT was 54 s (46-72 s; Range: 35-170 s). There was low fibrinogen [median: 1.3 g/L;1, -1.8 g/L; Range: < 0.2-2.9], low factor VIII levels [median: 23%; 16-37%] and low factor V levels [median: 43%; 23-74%]. D-Dimer concentrations [median: 3.4 mg/L; 2-7.4 mg/L] were slightly elevated. Factors II, VII and X and vWF antigen concentrations were normal. DISCUSSION AND CONCLUSIONS: Hump-nosed pit viper bites result in a mild coagulopathy which is usually not detected by a WBCT20. It is characterised by mild elevation of INR, low fibrinogen and Factors V and VIII which may be consistent with the venom containing a thrombin-like enzyme.


Assuntos
Transtornos da Coagulação Sanguínea/etiologia , Fatores de Coagulação Sanguínea/metabolismo , Coagulação Sanguínea , Venenos de Crotalídeos/sangue , Mordeduras de Serpentes/complicações , Viperidae , Adulto , Animais , Biomarcadores/sangue , Transtornos da Coagulação Sanguínea/sangue , Transtornos da Coagulação Sanguínea/diagnóstico , Transtornos da Coagulação Sanguínea/terapia , Regulação para Baixo , Fator V/metabolismo , Fator VIII/metabolismo , Feminino , Fibrinogênio/metabolismo , Humanos , Coeficiente Internacional Normatizado , Masculino , Pessoa de Meia-Idade , Tempo de Tromboplastina Parcial , Valor Preditivo dos Testes , Estudos Prospectivos , Tempo de Protrombina , Mordeduras de Serpentes/sangue , Mordeduras de Serpentes/diagnóstico , Mordeduras de Serpentes/terapia , Sri Lanka , Fatores de Tempo
6.
Int Immunopharmacol ; 17(4): 997-1001, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24455773

RESUMO

The pharmacokinetic profiles of Cryptelytrops purpureomaculatus (mangrove pit viper) venom following intravenous and intramuscular injections were investigated in rabbits. The serum levels of the venom were estimated using double-sandwich enzyme-linked immunosorbent assay (ELISA). After intravenous injection (0.2 mg/kg), the serum venom concentration­time course declined in a biexponential manner, consistent with a two-compartment model, with an α-phase half-life of 0.25 h and a ß-phase half-life of 27.7 h. The volume of distribution by area was 2.19 L/kg and systemic clearance was 54.7 mL/h/kg. When the venom was injected intramuscularly (0.5 mg/kg), the serum level increased rapidly to reach a peak (500 ng/mL) at about 1 h, which then declined rapidly to a plateau (104­142 ng/mL) at 3­10 h before further gradual decline until the end of the 72-hour study. The terminal half-life (27.0 h), clearance (54.7 mL/h/kg) and volume of distribution (2.13 L/kg) of the venom for intramuscular route were not significantly different from the corresponding values for intravenous route, and the intramuscular bioavailability of the venom was estimated to be 41.6%.


Assuntos
Venenos de Crotalídeos/farmacocinética , Animais , Venenos de Crotalídeos/administração & dosagem , Venenos de Crotalídeos/sangue , Injeções Intramusculares , Injeções Intravenosas , Masculino , Coelhos , Viperidae
7.
J Pharm Biomed Anal ; 70: 396-400, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22738788

RESUMO

The platelet receptor glycoprotein Ib-IX-V complex (GPIb-IX-V) plays a dominant role in the first step of platelet adhesion and arterial thrombus formation. Agkisacutacin, a C-type lectin-like protein (CLP) from Agkistrodon acutus venom, had been previously identified as an antagonist of platelet aggregation and a membrane glycoprotein Ib-binding protein (GPIb-bp). For the analysis of pharmacokinetics of agkisacutacin, an indirect sandwich enzyme-linked immunosorbent assay (ELISA) was established and validated to quantify agkisacutacin in human serum. The method was precise and accurate over the entire linear range of 1.0 and 1000 pg/mL with a lower limit of quantification of 1.0 pg/mL. The intra- and inter-assay coefficient of variation ranged from 0.7 to 4.2% and 1.1 to 4.1%, respectively. Recovery obtained from the accuracy test, using three concentration levels, varied between 96.1 and 110.6%, confirming the assay's reliability. The long-term study showed agkisacutacin was stable at -70 °C up to 46 days. This ELISA was first used to assess the pharmacokinetics of agkisacutacin in healthy volunteers. The characteristics of pharmacokinetic showed that agkisacutacin could rapidly combine with GPIb and slowly dissociate from GPIb-bound form in the body.


Assuntos
Venenos de Crotalídeos/sangue , Venenos de Crotalídeos/farmacocinética , Ensaio de Imunoadsorção Enzimática , Inibidores da Agregação Plaquetária/sangue , Inibidores da Agregação Plaquetária/farmacocinética , Área Sob a Curva , Povo Asiático , China , Temperatura Baixa , Venenos de Crotalídeos/administração & dosagem , Estabilidade de Medicamentos , Feminino , Meia-Vida , Humanos , Injeções Intravenosas , Limite de Detecção , Modelos Lineares , Masculino , Taxa de Depuração Metabólica , Inibidores da Agregação Plaquetária/administração & dosagem , Complexo Glicoproteico GPIb-IX de Plaquetas/metabolismo , Ligação Proteica , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
9.
J Nat Prod ; 74(10): 2168-73, 2011 Oct 28.
Artigo em Inglês | MEDLINE | ID: mdl-21962208

RESUMO

Three new solanidane alkaloids bearing a 22,23-epoxy ring (1-3) and four known compounds were isolated from leaves of Solanum campaniforme. The structures were determined using spectroscopic techniques, including 1D and 2D NMR, and HRESIMS experiments. The antiophidic activity of the alkaloids was tested against Bothrops pauloensis venom. Compounds 1-3 completely inhibited myotoxicity without inhibiting phospholipase A2 activity of the venom, while hemorrhage and skin necrosis were significantly reduced in the presence of alkaloids 1 and 2.


Assuntos
Alcaloides/isolamento & purificação , Alcaloides/farmacologia , Venenos de Crotalídeos/toxicidade , Solanum/química , Esteroides/isolamento & purificação , Esteroides/farmacologia , Alcaloides/química , Alcaloides/imunologia , Animais , Bothrops/fisiologia , Brasil , Venenos de Crotalídeos/sangue , Venenos de Crotalídeos/metabolismo , Estrutura Molecular , Ressonância Magnética Nuclear Biomolecular , Folhas de Planta/química , Esteroides/química
10.
Biosci Biotechnol Biochem ; 75(3): 480-8, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21389624

RESUMO

The cDNAs encoding venom phospholipase A(2) (PLA(2)) inhibitors (PLIs), named Protobothrops elegans (Pe)γPLI-A, PeγPLI-B, PeαPLI-A, and PeαPLI-B, were cloned from the P. elegans liver cDNA library. They were further divided into several constituents due to nucleotide substitutions in their open reading frames. For PeαPLI-A, two constituents, PeαPLI-A(a) and PeαPLI-A(b), were identified due to three nonsynonymous substitutions in exon 3. Far-western blot and mass-spectrometry analysis of the P. elegans serum proteins showed the presence of γPLIs, and αPLIs, which can bind venom PLA(2)s. In αPLIs from Protobothrops sera, A or B subtype-specific amino acid substitutions are concentrated only in exon 3. A comparison of γPLIs showed that γPLI-As are conserved and γPLI-Bs diversified. Mathematical analysis of the nucleotide sequences of Protobothrops γPLI-B cDNAs revealed that the particular loops in the three-finger motifs diversified by accelerated evolution. Such evolutionary features should have made serum PLIs acquire their respective inhibitory activities to adapt to venom PLA(2) isozymes.


Assuntos
Proteínas Sanguíneas/metabolismo , DNA Complementar/análise , Inibidores de Fosfolipase A2 , Isoformas de Proteínas/metabolismo , Proteínas Recombinantes/metabolismo , Sequência de Aminoácidos , Substituição de Aminoácidos , Animais , Sequência de Bases , Proteínas Sanguíneas/genética , Proteínas Sanguíneas/isolamento & purificação , Far-Western Blotting , Clonagem Molecular , Venenos de Crotalídeos/sangue , Venenos de Crotalídeos/química , Venenos de Crotalídeos/genética , Escherichia coli , Evolução Molecular , Éxons , Biblioteca Gênica , Fígado/química , Fígado/metabolismo , Dados de Sequência Molecular , Fosfolipases A2/sangue , Filogenia , Ligação Proteica/genética , Isoformas de Proteínas/genética , Isoformas de Proteínas/isolamento & purificação , Proteínas Recombinantes/genética , Proteínas Recombinantes/isolamento & purificação , Soro/química , Trimeresurus/sangue , Trimeresurus/genética
11.
Clin Toxicol (Phila) ; 48(1): 57-60, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-20095815

RESUMO

OBJECTIVE: To report the outcome of a patient who developed compartment syndrome after Bothrops jararaca snakebite. CASE REPORT: A 39-year-old male was admitted 5 h after being bitten on the lower right leg. Physical examination revealed tense swelling, ecchymosis, hypoesthesia, and intense local pain that worsened after passive stretching, limited right foot dorsiflexion, and gingival bleeding. The case was classified as moderate/severe and eight vials of bothropic antivenom (AV) were infused 1 h postadmission. The main laboratory findings upon admission were incoagulable blood (incoagulable PT, aPTT, and INR), thrombocytopenia, serum creatine kinase (CK) of 580 U/L (reference value < 170 U/L), and a serum venom level of 33.7 ng/mL (ELISA; cutoff = 2.3 ng/mL). High anterior compartment pressure (60 mmHg) was identified 8 h post bite, with progressively lower pressures after AV administration and limb elevation (36 mmHg; 19 h post bite). However, moderate pain and limited foot dorsiflexion persisted. In addition, there was a progressive increase in serum CK (6,729 U/L; 45 h post bite), as well as marked edema and hemorrhage of the anterior compartment detected by magnetic resonance imaging (MRI) at 48 h post bite. A fasciotomy done after a further increase in intracompartmental pressure (66 mmHg, 57 h post bite) revealed hemorrhage/necrosis of the anterior tibial muscle that subsequently required partial resection. The patient developed a local infection (day 15 post bite) and a permanent fibular palsy. CONCLUSION: Compartment syndrome is an unusual but severe complication of snakebites. MRI, in conjunction with subfascial pressure measurements, may be useful in the diagnosis of compartment syndrome after snakebites.


Assuntos
Bothrops , Síndromes Compartimentais/induzido quimicamente , Síndromes Compartimentais/terapia , Mordeduras de Serpentes/terapia , Animais , Antivenenos/uso terapêutico , Infecções Bacterianas/tratamento farmacológico , Infecções Bacterianas/etiologia , Biomarcadores , Síndromes Compartimentais/patologia , Venenos de Crotalídeos/sangue , Ensaio de Imunoadsorção Enzimática , Humanos , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Monitorização Fisiológica , Dor/tratamento farmacológico , Dor/etiologia , Pressão , Mordeduras de Serpentes/complicações , Mordeduras de Serpentes/patologia , Resultado do Tratamento
12.
Trop Doct ; 37(4): 207-10, 2007 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17988477

RESUMO

Green pit viper bite is a common public health problem in Southeast Asia. Although most patients experience only local swelling, some may suffer from severe systemic bleeding that can be delayed. Venom antigenaemia was measured by enzyme-linked immunosorbent assay and correlated with clinical findings in 42 patients. Initial venom antigenaemia was not predictive enough for clinical uses. A kinetic study (n = 27) showed highest levels at presentation and, then, progressive decline. The average half-life was 27.5 h during the first three days and over 50 h on days 5-7 after bite. Two small subsets (7.4% each) showed persistently detectable venom on day 14 and a subsequent rise in venom antigenaemia. They were associated with prolonged thrombocytopaenia and coagulopathy, respectively. These data demonstrated the long half-life of the venom, suggesting that waiting for spontaneous resolution of coagulopathy is not preferable. In addition, the delayed venom disappearance, not the initial values, was correlated with haemostatic disorders.


Assuntos
Antígenos/sangue , Venenos de Crotalídeos/sangue , Mordeduras de Serpentes , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Animais , Antivenenos/uso terapêutico , Venenos de Crotalídeos/imunologia , Ensaio de Imunoadsorção Enzimática , Extremidades/lesões , Feminino , Fibrinogênio/análise , Meia-Vida , Humanos , Cinética , Masculino , Pessoa de Meia-Idade , Agregação Plaquetária , Índice de Gravidade de Doença , Mordeduras de Serpentes/tratamento farmacológico , Mordeduras de Serpentes/fisiopatologia , Trombocitopenia , Fatores de Tempo , alfa 2-Antiplasmina/análise
13.
Trans R Soc Trop Med Hyg ; 100(12): 1173-82, 2006 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16698053

RESUMO

The efficacy and safety of two whole IgG polyvalent antivenoms (A and B) were compared in a randomised, blinded clinical trial in 67 patients systemically envenomed by Bothrops asper in Colombia. Both antivenoms were fractionated by caprylic acid precipitation and had similar neutralising potencies, protein concentrations and aggregate contents. Antivenom B was additionally treated with beta-propiolactone to lower its anticomplementary activity. Analysing all treatment regimens together, there were no significant differences between the two antivenoms (A=34 patients; B=33 patients) in the time taken to reverse venom-induced bleeding and coagulopathy, to restore physiological fibrinogen concentrations and to clear serum venom antigenaemia. Blood coagulability was restored within 6-24 h in 97% of patients, all of whom had normal coagulation and plasma fibrinogen levels 48 h after the start of antivenom treatment. Two patients (3.0%) had recurrent coagulopathy and eight patients suffered recurrence of antigenaemia within 72 h of treatment. None of the dosage regimens of either antivenom used guaranteed resolution of venom-induced coagulopathy within 6 h, nor did they prevent recurrences. A further dose of antivenom at 6 h also did not guarantee resolution of coagulopathy within 12-24 h in all patients. The incidence of early adverse reactions (all mild) was similar for both antivenoms (15% and 24%; P>0.05).


Assuntos
Antivenenos/uso terapêutico , Bothrops , Venenos de Crotalídeos/sangue , Mordeduras de Serpentes/tratamento farmacológico , Adolescente , Adulto , Idoso , Animais , Antivenenos/sangue , Antivenenos/química , Transtornos da Coagulação Sanguínea/tratamento farmacológico , Transtornos da Coagulação Sanguínea/etiologia , Caprilatos/farmacologia , Fracionamento Químico/métodos , Criança , Pré-Escolar , Relação Dose-Resposta a Droga , Ensaio de Imunoadsorção Enzimática , Feminino , Fibrinogênio/metabolismo , Humanos , Imunoglobulina G , Masculino , Camundongos , Pessoa de Meia-Idade , Propiolactona/farmacologia , Recidiva , Mordeduras de Serpentes/sangue , Resultado do Tratamento , Tempo de Coagulação do Sangue Total
14.
Trans R Soc Trop Med Hyg ; 100(9): 879-84, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16466758

RESUMO

Although systemic administration of antivenom can promptly reverse coagulopathy, efficacy on local effects of viper venom remains to be determined. Currently, there has been no proven specific treatment for snakebite patients with severe local effects. This study is a randomized, double-blind, placebo-controlled trial. Patients bitten by green pit vipers (Trimeresurus albolabris or T. macrops) with marked limb swelling, but no severe coagulopathy requiring antivenom, were randomized to receive either equine F(ab')2 antivenom, or placebo. Twenty-eight cases were included, 14 in each group, and they had their limb circumferences measured on days 1, 2, 4 and 6 after interventions. The percentage reduction in limb circumference was significantly better in the antivenom group compared with the placebo group (ANOVA, P = 0.03), especially in the first 24 h (1.14 vs. 3.62%, in placebo and antivenom group, respectively, P = 0.014). The reduction in pain score was similar. The plasma venom levels were not different at presentation but lower in the antivenom group 24h after intervention (P = 0.033). These data suggest that intravenous antivenom could accelerate local oedema resolution in humans. However, the degree is not clinically significant, and, therefore, general use is not recommended.


Assuntos
Antivenenos/uso terapêutico , Mordeduras de Serpentes/tratamento farmacológico , Trimeresurus , Adulto , Idoso , Idoso de 80 Anos ou mais , Animais , Venenos de Crotalídeos/sangue , Método Duplo-Cego , Edema/induzido quimicamente , Edema/tratamento farmacológico , Extremidades/lesões , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Dor/tratamento farmacológico , Mordeduras de Serpentes/patologia , Resultado do Tratamento
15.
Vet Hum Toxicol ; 44(6): 334-8, 2002 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-12458635

RESUMO

Dogs envenomed with non-lethal doses of Bothrops alternatus venom received standard antivenom therapy, im injections of flunixin meglumine, or topical treatmentwith aqueous Curcuma longa plant extract. Biodistribution of the venom and antivenom were determined by ELISA. There was no significant difference in the efficacy of antivenom and plant extract on local effects; flunixin treatment had lower efficacy. Distribution of the venom was similar with all 3 treatments. Serum levels of the antivenom reached maximum 2-4 h after administration and were not detected after the 5th d.


Assuntos
Anti-Inflamatórios não Esteroides/uso terapêutico , Antivenenos/uso terapêutico , Bothrops , Clonixina/análogos & derivados , Clonixina/uso terapêutico , Venenos de Crotalídeos/sangue , Fitoterapia , Preparações de Plantas/uso terapêutico , Animais , Anti-Inflamatórios não Esteroides/farmacocinética , Antivenenos/sangue , Clonixina/farmacocinética , Venenos de Crotalídeos/farmacocinética , Venenos de Crotalídeos/toxicidade , Curcuma , Cães , Ensaio de Imunoadsorção Enzimática , Feminino , Masculino
16.
QJM ; 94(10): 551-9, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11588214

RESUMO

The South American tropical rattlesnake (Crotalus durissus subspp) is responsible for approximately 10% of bites from venomous snakes in Brazil. We studied 24 victims of bites by this species over 3 years, in south-eastern Brazil, particularly investigating haemostatic alterations. Thirteen patients were defined as moderately envenomed and 11 as severe. There were two deaths, which were not attributed to venom-induced haemostatic disturbances. However, envenoming by C. durissus is frequently associated with haemostatic disorders, which are probably attributable mainly to the action of the thrombin-like enzyme, with possible additional effects secondary to the powerful myotoxic activity of the venom.


Assuntos
Antivenenos/uso terapêutico , Transtornos da Coagulação Sanguínea/etiologia , Venenos de Crotalídeos , Venenos de Crotalídeos/intoxicação , Mordeduras de Serpentes/sangue , Mordeduras de Serpentes/terapia , Adolescente , Adulto , Idoso , Animais , Transtornos da Coagulação Sanguínea/tratamento farmacológico , Brasil , Criança , Venenos de Crotalídeos/sangue , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Mordeduras de Serpentes/fisiopatologia
17.
Toxicon ; 37(5): 743-55, 1999 May.
Artigo em Inglês | MEDLINE | ID: mdl-10219986

RESUMO

Green pit viper (Trimeresurus albolabris and Trimeresurus macrops) venom was found to have a thrombin-like effect in vitro but cause a defibrination syndrome in vivo. The effects of venom on fibrinolytic system have not been well characterized. This knowledge can help to define the roles of antifibrinolytic therapy, give insights in fibrinolytic system regulation and potentially lead to identification of a new profibrinolytic agent from this venom. Forty-six cases of green pit viper bites were studied for various coagulation and fibrinolytic parameters and correlated with serum venom levels measured by ELISA. Fibrinolytic system activation is very common as indicated by low plasminogen (50%), low antiplasmin (56.5%) and elevated fibrin-fibrinogen degradation products (FDPs, 97.4%) levels. FDP test is very sensitive and a normal level is useful for exclusion of systemic envenomation. In contrast to some other models of defibrination syndrome, such as Russell viper (Daboia russelli siamensis), elevation of plasminogen activator activity (PA) was found indicating a hyperfibrinolytic state. Definite increase in tissue-type plasminogen activator (t-PA) antigen (p = 0.00075) with a modest elevation of its inhibitor plasminogen activator inhibitor-1 (PAI-1) (p = 0.27) probably contributes to this effect. This supports the idea that the balance between plasminogen activators and inhibitors can determine fibrinolytic responses in pathologic states. Fibrinopeptide A levels were markedly elevated (68.43 +/- 51.57 ng/ml in cases and 2.83 +/- 3.80 ng/ml in control, p < 0.0001) and correlated well with clinical severity suggesting that the fibrin deposition from the thrombin-like effect is the main mechanism of fibrinolysis. Therefore, antifibrinolytic agents probably have no role in treatment. However, the components of green pit viper venom that have these profibrinolytic effects in human are interesting and should be further identified.


Assuntos
Transtornos da Coagulação Sanguínea/induzido quimicamente , Venenos de Crotalídeos/efeitos adversos , Fibrinólise/efeitos dos fármacos , Agregação Plaquetária/efeitos dos fármacos , Mordeduras de Serpentes/complicações , Viperidae , Adulto , Animais , Antivenenos/uso terapêutico , Transtornos da Coagulação Sanguínea/fisiopatologia , Transtornos da Coagulação Sanguínea/terapia , Venenos de Crotalídeos/sangue , Ensaio de Imunoadsorção Enzimática , Feminino , Produtos de Degradação da Fibrina e do Fibrinogênio/análise , Fibrinólise/fisiologia , Fibrinolíticos/análise , Humanos , Masculino , Plasminogênio/análise , Inibidor 1 de Ativador de Plasminogênio/análise , Mordeduras de Serpentes/fisiopatologia , Mordeduras de Serpentes/terapia , Trombocitopenia/induzido quimicamente , Ativador de Plasminogênio Tecidual/análise , alfa 2-Antiplasmina/análise
18.
Am J Trop Med Hyg ; 58(2): 183-9, 1998 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-9580075

RESUMO

The therapeutic efficacy and the incidence of early antivenom reactions (EARs) were compared in a clinical trial performed in 79 patients bitten by Bothrops sp. in Urabá, Colombia. Patients were randomized into three groups according to the antivenom administered: A (n = 30, Butantan polyspecific, pepsin-digested Bothrops antivenom); B (n = 27, Butantan polyspecific, whole IgG Bothrops antivenom); and C (n = 22, Colombian commercial, monovalent, whole IgG Bothrops antivenom). The groups were comparable in all clinical and epidemiologic aspects; 33 patients had mild, 22 moderate, and 24 severe envenoming. At the doses used (two, four, and six vials [10 ml/vial] for mild, moderate, and severe envenomings, respectively) there were no differences between the antivenoms in restoring normal hemostatic parameters within 24 hr. The evolution of local envenoming was comparable in the three groups. Serum venom/antivenom kinetics determined by ELISA showed a complete clearance of venom levels 1 hr after treatment in mild/moderate envenomings. In severe cases, venom levels remained detectable up to 24 hr and recurrence of antigenemia was observed in some cases. Antivenom concentrations remained at high levels up to 24 hr of treatment. The incidence of EARs was significantly different in the groups: A (36.7%), B (11.1.%), and C (81.8%). There were no life-threatening anaphylactic reactions. We conclude that the efficacy of the three antivenoms was similar in neutralizing human Bothrops envenomings and that the production of whole IgG antivenoms by caprylic acid fractionation is a good alternative for reducing the incidence of EARs.


Assuntos
Antivenenos/uso terapêutico , Bothrops , Venenos de Crotalídeos/imunologia , Imunoglobulina G/uso terapêutico , Mordeduras de Serpentes/terapia , Adolescente , Adulto , Idoso , Animais , Antivenenos/efeitos adversos , Antivenenos/metabolismo , Criança , Pré-Escolar , Colômbia , Venenos de Crotalídeos/sangue , Método Duplo-Cego , Fibrinogênio/análise , Humanos , Imunoglobulina G/efeitos adversos , Pessoa de Meia-Idade , Pepsina A/metabolismo , Mordeduras de Serpentes/fisiopatologia
19.
Roum Arch Microbiol Immunol ; 57(3-4): 271-8, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-11845439

RESUMO

A double antibody sandwich enzyme linked immunosorbant assay (ELISA) was carried out to detect Bothrops Ianceolatus venom in plasma from envenomed patients at various time intervals (0, 6, 12, 18 and 24 hrs). The test could detect Bothrops lanceolatus levels up to 12 ng/mL of envenomed patient plasmas. Elaboration of an easy, fast and species-diagnostic based on this ELISA technique useful to physicians is discussed.


Assuntos
Bothrops , Venenos de Crotalídeos/análise , Ensaio de Imunoadsorção Enzimática , Mordeduras de Serpentes/sangue , Animais , Venenos de Crotalídeos/sangue , Feminino , Humanos , Masculino , Mordeduras de Serpentes/diagnóstico , Especificidade da Espécie , Fatores de Tempo
20.
Toxicon ; 35(8): 1217-28, 1997 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9278971

RESUMO

Convulxin, a very potent aggregating protein from rattlesnake venom, was purified by a new procedure and its heterodimeric structure alpha 3 beta 3 was confirmed. The polypeptide N-terminal sequences of convulxin subunits were determined by Edman degradation. They are very similar and appear homologous to botrocetin from Bothrops jararaca venom and to rattlesnake lectin from Crotalus atrox venom, both being classified among the C-type lectin family. The binding of 125I-labelled convulxin to blood platelets has also been analysed under equilibrium conditions. These studies indicated that convulxin binds to platelets with a high affinity (Kd = 30 pM) on a small number of binding sites (1000 binding sites per cell). The high-affinity binding of convulxin appears specific to platelets, since it is not observed on other cell types such as neutrophils and erythrocytes. Also, the high-affinity binding of convulxin to membranes platelet is not inhibited by alpha-thrombin, fibrinogen, collagen, laminin binding inhibitor, RGDS peptide, adenosine diphosphate, platelet-activating factor-acether, serotonin or epinephrine. This, together with the recent observation that platelet activation by convulxin is partially mediated by phospholipase C and involves other mechanisms as well, indicates that convulxin may interact with a specific platelet acceptor (receptor) protein which has yet to be characterized.


Assuntos
Plaquetas/metabolismo , Venenos de Crotalídeos/sangue , Venenos de Crotalídeos/química , Lectinas Tipo C , Agregação Plaquetária/efeitos dos fármacos , Sequência de Aminoácidos , Animais , Ligação Competitiva , Testes de Hemaglutinação , Radioisótopos do Iodo , Masculino , Dados de Sequência Molecular , Estrutura Molecular , Ligação Proteica , Coelhos , Ensaio Radioligante , Homologia de Sequência de Aminoácidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...